This New York Times piece highlights a major step forward by Cigna and Merck:
Merck has agreed to peg what the insurer Cigna pays for the diabetes drugs Januvia and Janumet to how well Type 2 diabetes patients are able …
This New York Times piece highlights a major step forward by Cigna and Merck:
Merck has agreed to peg what the insurer Cigna pays for the diabetes drugs Januvia and Janumet to how well Type 2 diabetes patients are able …
Jan Berger, a member of the CHVI board of directors, is co-author of the study Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents published in the April edition of Archives of Pediatric and Adolescent Medicine…